| name | Nizatidine |
| classification | H2-receptor antagonist |
| pharmacokinetics | Nizatidine is rapidly absorbed after oral administration. Peak plasma concentrations are reached within 1-2 hours. The drug is extensively metabolized in the liver. The primary metabolites are inactive. The elimination half-life is approximately 2 hours. The drug is primarily excreted in the urine. |
| suggested dosage | | adult | Typically 150 mg twice daily. Dosage may be adjusted based on individual patient response and clinical condition. |
|
| indications | | 1 | Peptic ulcer disease (prevention and treatment) | | 2 | Gastroesophageal reflux disease (GERD) | | 3 | Symptomatic relief of heartburn and acid indigestion |
|
| safety in pregnancy | Generally considered safe during pregnancy. Consult a healthcare professional for personalized advice. |
| safety in breastfeeding | Limited data available. Consult a healthcare professional before use. |
| side effects | | 1 | Headache | | 2 | Dizziness | | 3 | Diarrhea | | 4 | Constipation | | 5 | Nausea | | 6 | Vomiting | | 7 | Abdominal pain | | 8 | Skin rash | | 9 | Pruritus | | 10 | Gastrointestinal upset | | 11 | Rarely, severe liver problems |
|
| alternatives | |
| contraindications | | 1 | Known hypersensitivity to Nizatidine or other H2 receptor antagonists | | 2 | Severe hepatic impairment |
|
| interactions | | 1 | Potential interactions with drugs metabolized by the liver (e.g., some antidepressants, oral anticoagulants). Consult a healthcare professional for specific interactions. | | 2 | Alcohol consumption may increase the risk of side effects. |
|
| warnings and precautions | | 1 | Use with caution in patients with renal impairment. | | 2 | Monitor liver function tests periodically, especially in high-risk patients. | | 3 | Closely monitor patients with a history of allergic reactions. |
|
| additional information | | 1 | Available in tablets and suspensions. | | 2 | Take as directed by a healthcare professional. | | 3 | This information is for general knowledge only and does not constitute medical advice. Consult a healthcare professional before taking Nizatidine or any other medication. |
|
| patient information | | age | 25 years | | weight | 70 kg | | notes | Patient data provided for informational purposes only. This data should not be used to substitute professional medical advice. |
|
